# Your knee care choices should fit the problem *Options After Diagnosis | Knee Pain Treatment Scottsdale* > Knee pain treatment Scottsdale choices include movement, medicines, support, non-surgical care and later options. What can you do after a doctor names the cause? Start with the choice that matches your symptoms and daily limits. Many aching knees respond to a sound home plan. Medicine or a brace may make movement easier, while some knees need a procedure or a talk about surgery. A diagnosis narrows the choices, but it doesn't choose for you. ## Movement and support form the usual starting plan Exercise can strengthen the muscles that guide and protect your knee. It works best when the moves fit your weak spots. A therapist can teach safe form and raise the load slowly. If extra body weight adds strain, even a modest change may help. That talk belongs in a useful plan, not a lecture. A cane can share the load during walking. Some braces steady one part of the joint. Pain creams may ease soreness with less medicine reaching the rest of your body. Pills can help too, but stomach, kidney and heart risks matter. Your doctor can check them against your health and current medicines. The first choice should help you move with more comfort and trust. ## Procedures and surgery have different jobs Some procedures aim for short relief. Others are natural pain treatments meant to support the joint. PRP uses platelets, the blood parts that help with repair signals. Concentrated PRP has more platelets in a smaller amount of plasma. Results vary, so ask what change you could fairly expect. Surgery may make sense when pain is severe and daily function has fallen far. A knee or hip surgery alternative may be worth discussing before that point. No such option promises that surgery can always be avoided. Match the size of the treatment to the size of the problem. ## Persistent limits call for a careful treatment talk Seek another opinion when the plan hasn't helped enough or no longer makes sense. Bring your scan reports and medicine list. Describe the tasks that matter, such as sleeping, walking or using stairs. Those details give the visit a clear target. For lasting limits, QC Kinetix holds consultations. Its medical providers can explain orthobiologics, which are treatments made from substances found in the body. They can also discuss fit, cost, likely recovery and other non-surgical choices. Your plan needs to make sense and include a clear way to judge change. ## Sources 1. The 2019 ACR/Arthritis Foundation guideline makes STRONG recommendations for exercise, weight loss in people with overweight or obesity, self-efficacy and self-management programs, tai chi, cane use, tibiofemoral bracing, topical NSAIDs, oral NSAIDs and intra-articular glucocorticoid injections in knee OA; radiofrequency ablation for knee OA is only a conditional recommendation. Kolasinski SL, et al. — [2019 American College of Rheumatology/Arthritis Foundation Guideline for the Management of Osteoarthritis of the Hand, Hip, and Knee.](https://pubmed.ncbi.nlm.nih.gov/31908163/). *Arthritis & Rheumatology*, 2020. DOI: 10.1002/art.41142. 2. OARSI 2019 designates arthritis education plus structured land-based exercise (with or without dietary weight management) as CORE treatments for knee OA; topical NSAIDs are strongly recommended (Level 1A); oral and transdermal opioids are strongly NOT recommended (Level 5). Bannuru RR, et al. — [OARSI guidelines for the non-surgical management of knee, hip, and polyarticular osteoarthritis.](https://pubmed.ncbi.nlm.nih.gov/31278997/). *Osteoarthritis and Cartilage*, 2019. DOI: 10.1016/j.joca.2019.06.011. 3. High-quality evidence from 44 trials (3,537 participants) shows land-based exercise reduced knee OA pain by an equivalent of 12 points on a 0-100 scale (SMD -0.49) immediately after treatment, with moderate-quality evidence for a ~10-point function gain; the effect attenuated but persisted at 2-6 months (SMD -0.24). No serious adverse events were reported in any included trial. Fransen M, McConnell S, Harmer AR, Van der Esch M, Simic M, Bennell KL. — [Exercise for osteoarthritis of the knee.](https://pubmed.ncbi.nlm.nih.gov/25569281/). *Cochrane Database of Systematic Reviews*, 2015. DOI: 10.1002/14651858.CD004376.pub3. 4. A Cochrane review of topical NSAIDs for chronic musculoskeletal pain in adults synthesised randomised double-blind trials with stringent quality criteria, supporting topical NSAIDs as a route to pain relief without the systemic adverse events of oral NSAIDs — the basis for their strong guideline recommendation in knee OA. Derry S, Conaghan P, Da Silva JA, Wiffen PJ, Moore RA. — [Topical NSAIDs for chronic musculoskeletal pain in adults.](https://pubmed.ncbi.nlm.nih.gov/27103611/). *Cochrane Database of Systematic Reviews*, 2016. DOI: 10.1002/14651858.CD007400.pub3. 5. In a 2-year, double-blind RCT of 140 patients with symptomatic knee OA and ultrasound synovitis, intra-articular triamcinolone 40 mg every 12 weeks caused significantly GREATER cartilage volume loss than saline (index-compartment cartilage thickness change -0.21 mm vs -0.10 mm; between-group difference -0.11 mm, 95% CI -0.20 to -0.03) with NO significant difference in pain (-1.2 vs -1.9 on the WOMAC Likert pain subscale). McAlindon TE, LaValley MP, Harvey WF, et al. — [Effect of Intra-articular Triamcinolone vs Saline on Knee Cartilage Volume and Pain in Patients With Knee Osteoarthritis: A Randomized Clinical Trial.](https://pubmed.ncbi.nlm.nih.gov/28510679/). *JAMA*, 2017. DOI: 10.1001/jama.2017.5283. 6. The RESTORE trial randomized 288 adults aged 50+ with symptomatic mild-to-moderate medial knee OA to three weekly leukocyte-poor PRP injections or saline placebo. At 12 months, pain change was -2.1 vs -1.8 points (difference -0.4; 95% CI -0.9 to 0.2; P=.17) and medial tibial cartilage volume change was -1.4% vs -1.2% (P=.81). 29 of 31 prespecified secondary outcomes showed no significant between-group difference. The authors concluded the findings 'do not support use of PRP for the management of knee OA.' Bennell KL, Paterson KL, Metcalf BR, et al. — [Effect of Intra-articular Platelet-Rich Plasma vs Placebo Injection on Pain and Medial Tibial Cartilage Volume in Patients With Knee Osteoarthritis: The RESTORE Randomized Clinical Trial.](https://pubmed.ncbi.nlm.nih.gov/34812863/). *JAMA*, 2021. DOI: 10.1001/jama.2021.19415. 7. A 2026 network meta-analysis of 21 RCTs (2,254 patients) found both leukocyte-poor and leukocyte-rich PRP significantly improved 6-12 month WOMAC function versus placebo (MD -10.54 and -13.20 respectively) and both were superior to hyaluronic acid, with leukocyte-poor PRP ranked first (P-score 0.96) — a materially more favourable read of PRP than the RESTORE trial, which is why this corpus presents both. Journal of Orthopaedic Surgery and Research authors — [Leukocyte-rich versus leukocyte-poor platelet-rich plasma and hyaluronic acid for knee osteoarthritis: a systematic review and network meta-analysis.](https://pubmed.ncbi.nlm.nih.gov/41629990/). *Journal of Orthopaedic Surgery and Research*, 2026. DOI: 10.1186/s13018-026-06689-4. 8. FDA states verbatim: 'None of these products have been approved for the treatment of any orthopedic condition, such as osteoarthritis, tendonitis, disc disease, tennis elbow, back pain, hip pain, knee pain, neck pain, or shoulder pain.' The only FDA-approved stem cell products in the United States are blood-forming (hematopoietic progenitor) cells derived from umbilical cord blood, approved only for disorders of blood production. There are currently NO FDA-approved exosome products. U.S. Food and Drug Administration — [Consumer Alert on Regenerative Medicine Products Including Stem Cells and Exosomes](https://www.fda.gov/vaccines-blood-biologics/consumers-biologics/consumer-alert-regenerative-medicine-products-including-stem-cells-and-exosomes). *FDA (Center for Biologics Evaluation and Research)*, 2020. 9. In a randomized trial of 100 patients with moderate-to-severe knee OA eligible for total knee replacement, TKR followed by 12 weeks of non-surgical care improved the KOOS4 score more than the same non-surgical programme alone (32.5 vs 16.0 points; adjusted mean difference 15.8, 95% CI 10.0 to 21.5) — but produced four times as many serious adverse events (24 vs 6, P=0.005), and 26% of the non-surgical group had chosen surgery within 12 months, meaning roughly three-quarters had not. Skou ST, Roos EM, Laursen MB, et al. — [A Randomized, Controlled Trial of Total Knee Replacement.](https://pubmed.ncbi.nlm.nih.gov/26488691/). *New England Journal of Medicine*, 2015. DOI: 10.1056/NEJMoa1505467. 10. A prospective longitudinal study of 64 patients with acute medial meniscus posterior root tear managed non-operatively found 76.6% continued non-operative care and only 23.4% converted to surgery (median 6 months). Pain fell from 7.6 to 1.3 on an 11-point scale within 6 months and stayed there — even though structural degeneration on MRI progressed. Symptoms and structure moved in opposite directions. Knee Surgery, Sports Traumatology, Arthroscopy authors — [Clinical improvement despite structural degeneration after nonoperative treatment of medial meniscus posterior root tear: A prospective longitudinal study.](https://pubmed.ncbi.nlm.nih.gov/42573108/). *Knee Surgery, Sports Traumatology, Arthroscopy*, 2026. DOI: 10.1002/ksa.70570. 11. A phase II multicentre RCT randomized 60 knee OA patients to three weekly PRGF injections or 100 million cultured autologous bone marrow mesenchymal stromal cells plus PRGF. No adverse effects were reported. VAS pain improved significantly in the BM-MSC+PRGF arm (5.3 to 3.5, p=0.01) but not in the PRGF-alone arm (5.0 to 4.5, p=0.389) at 12 months — a positive signal at small scale, in an unblinded active-control design. Lamo-Espinosa JM, et al. — [Phase II multicenter randomized controlled clinical trial on the efficacy of intra-articular injection of autologous bone marrow mesenchymal stem cells with platelet rich plasma for the treatment of knee osteoarthritis.](https://pubmed.ncbi.nlm.nih.gov/32948200/). *Journal of Translational Medicine*, 2020. DOI: 10.1186/s12967-020-02530-6. 12. A safety review of intra-articular PRP in knee OA found significantly higher rates of mild knee pain and swelling than hyaluronic acid (p<0.001), driven specifically by leukocyte-RICH formulations; leukocyte-poor PRP showed a safety profile similar to HA. No severe adverse events were reported in any group. PM&R authors — [Assessment of adverse events and safety associated with intra-articular platelet-rich plasma injections compared with hyaluronic acid and saline in knee osteoarthritis.](https://pubmed.ncbi.nlm.nih.gov/42101047/). *PM&R*, 2026. DOI: 10.1002/pmrj.70141. 13. In the Johnston County Osteoarthritis Project (3,068 adults aged 45+), the lifetime risk of developing symptomatic knee OA was 44.7% (95% CI 40.0-49.3%). Risk rose to 56.8% among those with a history of knee injury and to roughly two in three among people who were obese. Murphy L, Schwartz TA, Helmick CG, et al. — [Lifetime risk of symptomatic knee osteoarthritis.](https://pubmed.ncbi.nlm.nih.gov/18759314/). *Arthritis & Rheumatism*, 2008. DOI: 10.1002/art.24021. ## Bring your knee picture and the story behind the ache If the soreness hasn't eased, describe where it starts and which tasks are harder. Bring old reports and your medicine list. Ask what the exam suggests, whether another picture would help and how you will judge progress. The Scottsdale office is in the Mountain View Road medical corridor east of Loop 101. Call the Phoenix-area clinic team at (602) 837-PAIN. Book a free consultation: --- Your symptoms and your knee picture answer different questions. Knee pain treatment Scottsdale guidance for an aching joint, from relief at home to signs that need an exam. Plain Scottsdale guidance for understanding a sore knee, choosing a next step and knowing when to seek care. This site is operated by the owners of the QC Kinetix Phoenix-area clinics, and it openly recommends their Scottsdale location as a first-party business that benefits when readers book. © 2026 Scottsdale Knee Field Notes. General education, not medical advice for an individual knee; seek qualified in-person care for diagnosis and urgent symptoms.